nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—CYP3A4—Clindamycin—malaria	0.153	0.268	CbGbCtD
Fulvestrant—CYP3A4—Sulfadiazine—malaria	0.088	0.154	CbGbCtD
Fulvestrant—CYP3A4—Artemether—malaria	0.0748	0.131	CbGbCtD
Fulvestrant—CYP3A4—Proguanil—malaria	0.0703	0.123	CbGbCtD
Fulvestrant—CYP3A4—Doxycycline—malaria	0.0667	0.116	CbGbCtD
Fulvestrant—CYP3A4—Quinine—malaria	0.0453	0.0792	CbGbCtD
Fulvestrant—CYP3A4—Quinidine—malaria	0.0398	0.0696	CbGbCtD
Fulvestrant—CYP3A4—Dapsone—malaria	0.0343	0.06	CbGbCtD
Fulvestrant—NR1H4—hematopoietic system—malaria	0.0097	0.0817	CbGeAlD
Fulvestrant—NR1H4—kidney—malaria	0.00795	0.067	CbGeAlD
Fulvestrant—ESRRA—saliva-secreting gland—malaria	0.00779	0.0655	CbGeAlD
Fulvestrant—NR1H4—digestive system—malaria	0.00675	0.0568	CbGeAlD
Fulvestrant—ESRRA—kidney—malaria	0.00609	0.0513	CbGeAlD
Fulvestrant—EPHX2—blood—malaria	0.00562	0.0473	CbGeAlD
Fulvestrant—ESRRA—digestive system—malaria	0.00517	0.0435	CbGeAlD
Fulvestrant—Vaginal moniliasis—Clindamycin—malaria	0.00507	0.0175	CcSEcCtD
Fulvestrant—NR1H4—liver—malaria	0.00503	0.0423	CbGeAlD
Fulvestrant—ESRRA—blood—malaria	0.00492	0.0414	CbGeAlD
Fulvestrant—Vulvovaginal candidiasis—Clindamycin—malaria	0.00486	0.0168	CcSEcCtD
Fulvestrant—ESRRA—bone marrow—malaria	0.00476	0.0401	CbGeAlD
Fulvestrant—Vulvovaginal mycotic infection—Clindamycin—malaria	0.00468	0.0161	CcSEcCtD
Fulvestrant—ESR2—hematopoietic system—malaria	0.00446	0.0375	CbGeAlD
Fulvestrant—EPHX2—liver—malaria	0.00439	0.037	CbGeAlD
Fulvestrant—Gastrointestinal symptom NOS—Clindamycin—malaria	0.00435	0.015	CcSEcCtD
Fulvestrant—Gastrointestinal symptom NOS—Quinine—malaria	0.00427	0.0147	CcSEcCtD
Fulvestrant—Gastrointestinal symptom NOS—Quinidine—malaria	0.00427	0.0147	CcSEcCtD
Fulvestrant—Vaginal discharge—Clindamycin—malaria	0.0042	0.0145	CcSEcCtD
Fulvestrant—Pelvic pain—Clindamycin—malaria	0.0042	0.0145	CcSEcCtD
Fulvestrant—Gastrointestinal symptom NOS—Quinidine barbiturate—malaria	0.00385	0.0133	CcSEcCtD
Fulvestrant—ESRRA—liver—malaria	0.00385	0.0324	CbGeAlD
Fulvestrant—Digestion impaired—Clindamycin—malaria	0.00382	0.0132	CcSEcCtD
Fulvestrant—ESR2—kidney—malaria	0.00365	0.0308	CbGeAlD
Fulvestrant—EPHX2—brain—malaria	0.00349	0.0294	CbGeAlD
Fulvestrant—Vaginal haemorrhage—Clindamycin—malaria	0.00345	0.0119	CcSEcCtD
Fulvestrant—ESR2—digestive system—malaria	0.0031	0.0261	CbGeAlD
Fulvestrant—CYP3A4—blood plasma—malaria	0.00308	0.0259	CbGeAlD
Fulvestrant—ESRRA—brain—malaria	0.00305	0.0257	CbGeAlD
Fulvestrant—ESR1—hematopoietic system—malaria	0.00305	0.0257	CbGeAlD
Fulvestrant—ESR2—blood—malaria	0.00295	0.0249	CbGeAlD
Fulvestrant—Vasodilation—Quinidine—malaria	0.00285	0.00984	CcSEcCtD
Fulvestrant—Vasodilation procedure—Quinine—malaria	0.00285	0.00984	CcSEcCtD
Fulvestrant—Vasodilation—Quinine—malaria	0.00285	0.00984	CcSEcCtD
Fulvestrant—Vasodilation procedure—Quinidine—malaria	0.00285	0.00984	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Proguanil—malaria	0.00274	0.00943	CcSEcCtD
Fulvestrant—Inflammation—Clindamycin—malaria	0.00264	0.00908	CcSEcCtD
Fulvestrant—Leukopenia—Pyrimethamine—malaria	0.0026	0.00895	CcSEcCtD
Fulvestrant—Vasodilation procedure—Quinidine barbiturate—malaria	0.00258	0.00888	CcSEcCtD
Fulvestrant—Vasodilation—Quinidine barbiturate—malaria	0.00258	0.00888	CcSEcCtD
Fulvestrant—ESR1—kidney—malaria	0.0025	0.0211	CbGeAlD
Fulvestrant—Immune system disorder—Proguanil—malaria	0.00235	0.00808	CcSEcCtD
Fulvestrant—ESR2—liver—malaria	0.00231	0.0194	CbGeAlD
Fulvestrant—Malnutrition—Proguanil—malaria	0.00226	0.00779	CcSEcCtD
Fulvestrant—Anorexia—Pyrimethamine—malaria	0.00226	0.00778	CcSEcCtD
Fulvestrant—Injection site reaction—Quinidine barbiturate—malaria	0.00225	0.00775	CcSEcCtD
Fulvestrant—ESR1—digestive system—malaria	0.00212	0.0179	CbGeAlD
Fulvestrant—Decreased appetite—Pyrimethamine—malaria	0.00206	0.0071	CcSEcCtD
Fulvestrant—ESR1—blood—malaria	0.00202	0.017	CbGeAlD
Fulvestrant—Cough—Proguanil—malaria	0.00197	0.0068	CcSEcCtD
Fulvestrant—Depression—Sulfadiazine—malaria	0.00192	0.0066	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00191	0.00659	CcSEcCtD
Fulvestrant—ESR2—brain—malaria	0.00183	0.0154	CbGeAlD
Fulvestrant—Nervous system disorder—Proguanil—malaria	0.00181	0.00624	CcSEcCtD
Fulvestrant—Skin disorder—Proguanil—malaria	0.00179	0.00618	CcSEcCtD
Fulvestrant—Anorexia—Proguanil—malaria	0.00176	0.00606	CcSEcCtD
Fulvestrant—Hypersensitivity—Pyrimethamine—malaria	0.00175	0.00601	CcSEcCtD
Fulvestrant—Hepatitis—Sulfadiazine—malaria	0.00172	0.00594	CcSEcCtD
Fulvestrant—CYP3A4—hematopoietic system—malaria	0.0017	0.0143	CbGeAlD
Fulvestrant—Influenza—Dapsone—malaria	0.00166	0.00571	CcSEcCtD
Fulvestrant—Breast disorder—Quinine—malaria	0.00165	0.00567	CcSEcCtD
Fulvestrant—Breast disorder—Quinidine—malaria	0.00165	0.00567	CcSEcCtD
Fulvestrant—EPHX2—Arachidonic acid metabolism—HPGDS—malaria	0.00163	0.0872	CbGpPWpGaD
Fulvestrant—Decreased appetite—Proguanil—malaria	0.0016	0.00553	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Proguanil—malaria	0.00159	0.00549	CcSEcCtD
Fulvestrant—ESR1—liver—malaria	0.00158	0.0133	CbGeAlD
Fulvestrant—Gastrointestinal pain—Proguanil—malaria	0.00151	0.0052	CcSEcCtD
Fulvestrant—Vomiting—Pyrimethamine—malaria	0.00151	0.00519	CcSEcCtD
Fulvestrant—Breast disorder—Quinidine barbiturate—malaria	0.00148	0.00512	CcSEcCtD
Fulvestrant—ESR2—Validated nuclear estrogen receptor alpha network—MPG—malaria	0.00148	0.0793	CbGpPWpGaD
Fulvestrant—Body temperature increased—Proguanil—malaria	0.00146	0.00503	CcSEcCtD
Fulvestrant—Abdominal pain—Proguanil—malaria	0.00146	0.00503	CcSEcCtD
Fulvestrant—CYP3A4—kidney—malaria	0.0014	0.0118	CbGeAlD
Fulvestrant—Urinary tract infection—Clindamycin—malaria	0.00139	0.00479	CcSEcCtD
Fulvestrant—Vertigo—Sulfadiazine—malaria	0.00135	0.00465	CcSEcCtD
Fulvestrant—Sweating—Quinidine—malaria	0.00135	0.00463	CcSEcCtD
Fulvestrant—Sweating—Quinine—malaria	0.00135	0.00463	CcSEcCtD
Fulvestrant—Leukopenia—Sulfadiazine—malaria	0.00134	0.00463	CcSEcCtD
Fulvestrant—Pharyngitis—Dapsone—malaria	0.00132	0.00454	CcSEcCtD
Fulvestrant—Arthralgia—Sulfadiazine—malaria	0.00128	0.0044	CcSEcCtD
Fulvestrant—Haemoglobin—Quinine—malaria	0.00127	0.00436	CcSEcCtD
Fulvestrant—Haemoglobin—Quinidine—malaria	0.00127	0.00436	CcSEcCtD
Fulvestrant—Infestation NOS—Pentoxifylline—malaria	0.00126	0.00436	CcSEcCtD
Fulvestrant—Infestation—Pentoxifylline—malaria	0.00126	0.00436	CcSEcCtD
Fulvestrant—Diarrhoea—Proguanil—malaria	0.00126	0.00435	CcSEcCtD
Fulvestrant—Hepatitis—Quinine—malaria	0.00126	0.00434	CcSEcCtD
Fulvestrant—Haemorrhage—Quinidine—malaria	0.00126	0.00434	CcSEcCtD
Fulvestrant—Hepatitis—Quinidine—malaria	0.00126	0.00434	CcSEcCtD
Fulvestrant—Haemorrhage—Quinine—malaria	0.00126	0.00434	CcSEcCtD
Fulvestrant—ESR1—brain—malaria	0.00126	0.0106	CbGeAlD
Fulvestrant—Sweating—Quinidine barbiturate—malaria	0.00121	0.00418	CcSEcCtD
Fulvestrant—Sweating—Pentoxifylline—malaria	0.00121	0.00418	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Pentoxifylline—malaria	0.0012	0.00412	CcSEcCtD
Fulvestrant—CYP3A4—digestive system—malaria	0.00119	0.00998	CbGeAlD
Fulvestrant—Vomiting—Proguanil—malaria	0.00117	0.00404	CcSEcCtD
Fulvestrant—Anorexia—Sulfadiazine—malaria	0.00117	0.00402	CcSEcCtD
Fulvestrant—Rash—Proguanil—malaria	0.00116	0.00401	CcSEcCtD
Fulvestrant—Dermatitis—Proguanil—malaria	0.00116	0.00401	CcSEcCtD
Fulvestrant—Headache—Proguanil—malaria	0.00116	0.00398	CcSEcCtD
Fulvestrant—Haemoglobin—Quinidine barbiturate—malaria	0.00114	0.00394	CcSEcCtD
Fulvestrant—Haemoglobin—Pentoxifylline—malaria	0.00114	0.00393	CcSEcCtD
Fulvestrant—Immune system disorder—Quinine—malaria	0.00114	0.00392	CcSEcCtD
Fulvestrant—Immune system disorder—Quinidine—malaria	0.00114	0.00392	CcSEcCtD
Fulvestrant—Haemorrhage—Quinidine barbiturate—malaria	0.00114	0.00392	CcSEcCtD
Fulvestrant—Hepatitis—Quinidine barbiturate—malaria	0.00114	0.00392	CcSEcCtD
Fulvestrant—Haemorrhage—Pentoxifylline—malaria	0.00113	0.00391	CcSEcCtD
Fulvestrant—Hepatitis—Pentoxifylline—malaria	0.00113	0.00391	CcSEcCtD
Fulvestrant—CYP3A4—blood—malaria	0.00113	0.0095	CbGeAlD
Fulvestrant—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00112	0.00385	CcSEcCtD
Fulvestrant—Insomnia—Sulfadiazine—malaria	0.00111	0.00382	CcSEcCtD
Fulvestrant—Malnutrition—Quinine—malaria	0.0011	0.00378	CcSEcCtD
Fulvestrant—Malnutrition—Quinidine—malaria	0.0011	0.00378	CcSEcCtD
Fulvestrant—Nausea—Proguanil—malaria	0.0011	0.00378	CcSEcCtD
Fulvestrant—Back pain—Clindamycin—malaria	0.00108	0.00373	CcSEcCtD
Fulvestrant—Decreased appetite—Sulfadiazine—malaria	0.00106	0.00367	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Sulfadiazine—malaria	0.00106	0.00364	CcSEcCtD
Fulvestrant—Vertigo—Dapsone—malaria	0.00104	0.00358	CcSEcCtD
Fulvestrant—Anaemia—Clindamycin—malaria	0.00103	0.00356	CcSEcCtD
Fulvestrant—Immune system disorder—Quinidine barbiturate—malaria	0.00103	0.00354	CcSEcCtD
Fulvestrant—Immune system disorder—Pentoxifylline—malaria	0.00102	0.00353	CcSEcCtD
Fulvestrant—Cough—Dapsone—malaria	0.00101	0.00347	CcSEcCtD
Fulvestrant—Vertigo—Clindamycin—malaria	0.001	0.00346	CcSEcCtD
Fulvestrant—Angioedema—Quinine—malaria	0.001	0.00345	CcSEcCtD
Fulvestrant—Angioedema—Quinidine—malaria	0.001	0.00345	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Sulfadiazine—malaria	0.001	0.00345	CcSEcCtD
Fulvestrant—Leukopenia—Clindamycin—malaria	0.001	0.00345	CcSEcCtD
Fulvestrant—Malnutrition—Quinidine barbiturate—malaria	0.00099	0.00341	CcSEcCtD
Fulvestrant—Vertigo—Quinidine—malaria	0.000985	0.00339	CcSEcCtD
Fulvestrant—Vertigo—Quinine—malaria	0.000985	0.00339	CcSEcCtD
Fulvestrant—Leukopenia—Quinine—malaria	0.000981	0.00338	CcSEcCtD
Fulvestrant—Leukopenia—Quinidine—malaria	0.000981	0.00338	CcSEcCtD
Fulvestrant—Urticaria—Sulfadiazine—malaria	0.000973	0.00335	CcSEcCtD
Fulvestrant—Body temperature increased—Sulfadiazine—malaria	0.000968	0.00334	CcSEcCtD
Fulvestrant—Abdominal pain—Sulfadiazine—malaria	0.000968	0.00334	CcSEcCtD
Fulvestrant—Back pain—Pentoxifylline—malaria	0.000955	0.00329	CcSEcCtD
Fulvestrant—Chest pain—Quinidine—malaria	0.000933	0.00322	CcSEcCtD
Fulvestrant—Myalgia—Quinidine—malaria	0.000933	0.00322	CcSEcCtD
Fulvestrant—Chest pain—Quinine—malaria	0.000933	0.00322	CcSEcCtD
Fulvestrant—Myalgia—Quinine—malaria	0.000933	0.00322	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000927	0.00319	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000927	0.00319	CcSEcCtD
Fulvestrant—Anaemia—Pentoxifylline—malaria	0.000913	0.00315	CcSEcCtD
Fulvestrant—Angioedema—Quinidine barbiturate—malaria	0.000904	0.00312	CcSEcCtD
Fulvestrant—Angioedema—Pentoxifylline—malaria	0.000903	0.00311	CcSEcCtD
Fulvestrant—Hypersensitivity—Sulfadiazine—malaria	0.000902	0.00311	CcSEcCtD
Fulvestrant—Vertigo—Quinidine barbiturate—malaria	0.000889	0.00306	CcSEcCtD
Fulvestrant—Leukopenia—Quinidine barbiturate—malaria	0.000886	0.00305	CcSEcCtD
Fulvestrant—Leukopenia—Pentoxifylline—malaria	0.000884	0.00305	CcSEcCtD
Fulvestrant—CYP3A4—liver—malaria	0.000883	0.00743	CbGeAlD
Fulvestrant—Nervous system disorder—Quinine—malaria	0.000878	0.00302	CcSEcCtD
Fulvestrant—Nervous system disorder—Quinidine—malaria	0.000878	0.00302	CcSEcCtD
Fulvestrant—Skin disorder—Quinidine—malaria	0.000869	0.00299	CcSEcCtD
Fulvestrant—Skin disorder—Quinine—malaria	0.000869	0.00299	CcSEcCtD
Fulvestrant—Pruritus—Sulfadiazine—malaria	0.000867	0.00299	CcSEcCtD
Fulvestrant—Hyperhidrosis—Quinidine—malaria	0.000865	0.00298	CcSEcCtD
Fulvestrant—Hyperhidrosis—Quinine—malaria	0.000865	0.00298	CcSEcCtD
Fulvestrant—Anorexia—Quinidine—malaria	0.000853	0.00294	CcSEcCtD
Fulvestrant—Anorexia—Quinine—malaria	0.000853	0.00294	CcSEcCtD
Fulvestrant—Insomnia—Dapsone—malaria	0.000853	0.00294	CcSEcCtD
Fulvestrant—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.000851	0.0457	CbGpPWpGaD
Fulvestrant—Myalgia—Quinidine barbiturate—malaria	0.000842	0.0029	CcSEcCtD
Fulvestrant—Chest pain—Quinidine barbiturate—malaria	0.000842	0.0029	CcSEcCtD
Fulvestrant—Arthralgia—Quinidine barbiturate—malaria	0.000842	0.0029	CcSEcCtD
Fulvestrant—Chest pain—Pentoxifylline—malaria	0.000841	0.0029	CcSEcCtD
Fulvestrant—Myalgia—Pentoxifylline—malaria	0.000841	0.0029	CcSEcCtD
Fulvestrant—Anxiety—Quinidine barbiturate—malaria	0.00084	0.00289	CcSEcCtD
Fulvestrant—Diarrhoea—Sulfadiazine—malaria	0.000838	0.00289	CcSEcCtD
Fulvestrant—Anxiety—Pentoxifylline—malaria	0.000838	0.00289	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000837	0.00288	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000835	0.00288	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Quinidine—malaria	0.000815	0.00281	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Quinine—malaria	0.000815	0.00281	CcSEcCtD
Fulvestrant—Dyspnoea—Clindamycin—malaria	0.000813	0.0028	CcSEcCtD
Fulvestrant—Dyspepsia—Clindamycin—malaria	0.000803	0.00277	CcSEcCtD
Fulvestrant—Infection—Pentoxifylline—malaria	0.000801	0.00276	CcSEcCtD
Fulvestrant—Dyspnoea—Quinine—malaria	0.000798	0.00275	CcSEcCtD
Fulvestrant—Dyspnoea—Quinidine—malaria	0.000798	0.00275	CcSEcCtD
Fulvestrant—Nervous system disorder—Quinidine barbiturate—malaria	0.000792	0.00273	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Clindamycin—malaria	0.000788	0.00271	CcSEcCtD
Fulvestrant—Fatigue—Clindamycin—malaria	0.000786	0.00271	CcSEcCtD
Fulvestrant—Skin disorder—Quinidine barbiturate—malaria	0.000784	0.0027	CcSEcCtD
Fulvestrant—Skin disorder—Pentoxifylline—malaria	0.000783	0.0027	CcSEcCtD
Fulvestrant—Hyperhidrosis—Quinidine barbiturate—malaria	0.000781	0.00269	CcSEcCtD
Fulvestrant—Constipation—Clindamycin—malaria	0.00078	0.00269	CcSEcCtD
Fulvestrant—Pain—Clindamycin—malaria	0.00078	0.00269	CcSEcCtD
Fulvestrant—Hyperhidrosis—Pentoxifylline—malaria	0.000779	0.00269	CcSEcCtD
Fulvestrant—Vomiting—Sulfadiazine—malaria	0.000779	0.00268	CcSEcCtD
Fulvestrant—Decreased appetite—Quinine—malaria	0.000778	0.00268	CcSEcCtD
Fulvestrant—Decreased appetite—Quinidine—malaria	0.000778	0.00268	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Quinidine—malaria	0.000773	0.00266	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Quinine—malaria	0.000773	0.00266	CcSEcCtD
Fulvestrant—Rash—Sulfadiazine—malaria	0.000772	0.00266	CcSEcCtD
Fulvestrant—Dermatitis—Sulfadiazine—malaria	0.000772	0.00266	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Dapsone—malaria	0.000771	0.00266	CcSEcCtD
Fulvestrant—Anorexia—Quinidine barbiturate—malaria	0.00077	0.00265	CcSEcCtD
Fulvestrant—Anorexia—Pentoxifylline—malaria	0.000768	0.00265	CcSEcCtD
Fulvestrant—Headache—Sulfadiazine—malaria	0.000767	0.00264	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Clindamycin—malaria	0.000746	0.00257	CcSEcCtD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—MPG—malaria	0.000746	0.04	CbGpPWpGaD
Fulvestrant—Body temperature increased—Dapsone—malaria	0.000745	0.00257	CcSEcCtD
Fulvestrant—Abdominal pain—Dapsone—malaria	0.000745	0.00257	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000736	0.00254	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000734	0.00253	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Quinidine—malaria	0.000732	0.00252	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Quinine—malaria	0.000732	0.00252	CcSEcCtD
Fulvestrant—Insomnia—Pentoxifylline—malaria	0.000729	0.00251	CcSEcCtD
Fulvestrant—Nausea—Sulfadiazine—malaria	0.000728	0.00251	CcSEcCtD
Fulvestrant—Urticaria—Clindamycin—malaria	0.000725	0.0025	CcSEcCtD
Fulvestrant—Abdominal pain—Clindamycin—malaria	0.000721	0.00248	CcSEcCtD
Fulvestrant—Body temperature increased—Clindamycin—malaria	0.000721	0.00248	CcSEcCtD
Fulvestrant—Dyspnoea—Quinidine barbiturate—malaria	0.00072	0.00248	CcSEcCtD
Fulvestrant—Dyspnoea—Pentoxifylline—malaria	0.000719	0.00248	CcSEcCtD
Fulvestrant—Urticaria—Quinidine—malaria	0.000711	0.00245	CcSEcCtD
Fulvestrant—Urticaria—Quinine—malaria	0.000711	0.00245	CcSEcCtD
Fulvestrant—Dyspepsia—Pentoxifylline—malaria	0.00071	0.00245	CcSEcCtD
Fulvestrant—Body temperature increased—Quinine—malaria	0.000707	0.00244	CcSEcCtD
Fulvestrant—Body temperature increased—Quinidine—malaria	0.000707	0.00244	CcSEcCtD
Fulvestrant—Abdominal pain—Quinidine—malaria	0.000707	0.00244	CcSEcCtD
Fulvestrant—Abdominal pain—Quinine—malaria	0.000707	0.00244	CcSEcCtD
Fulvestrant—Decreased appetite—Quinidine barbiturate—malaria	0.000702	0.00242	CcSEcCtD
Fulvestrant—Decreased appetite—Pentoxifylline—malaria	0.000701	0.00241	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000697	0.0024	CcSEcCtD
Fulvestrant—Constipation—Quinidine barbiturate—malaria	0.000691	0.00238	CcSEcCtD
Fulvestrant—Pain—Quinidine barbiturate—malaria	0.000691	0.00238	CcSEcCtD
Fulvestrant—Constipation—Pentoxifylline—malaria	0.000689	0.00238	CcSEcCtD
Fulvestrant—Hypersensitivity—Clindamycin—malaria	0.000672	0.00232	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00066	0.00228	CcSEcCtD
Fulvestrant—Hypersensitivity—Quinidine—malaria	0.000659	0.00227	CcSEcCtD
Fulvestrant—Hypersensitivity—Quinine—malaria	0.000659	0.00227	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Pentoxifylline—malaria	0.000659	0.00227	CcSEcCtD
Fulvestrant—Asthenia—Clindamycin—malaria	0.000654	0.00226	CcSEcCtD
Fulvestrant—Pruritus—Clindamycin—malaria	0.000645	0.00222	CcSEcCtD
Fulvestrant—Asthenia—Quinine—malaria	0.000642	0.00221	CcSEcCtD
Fulvestrant—Asthenia—Quinidine—malaria	0.000642	0.00221	CcSEcCtD
Fulvestrant—Urticaria—Quinidine barbiturate—malaria	0.000642	0.00221	CcSEcCtD
Fulvestrant—Urticaria—Pentoxifylline—malaria	0.00064	0.00221	CcSEcCtD
Fulvestrant—Abdominal pain—Quinidine barbiturate—malaria	0.000638	0.0022	CcSEcCtD
Fulvestrant—Body temperature increased—Quinidine barbiturate—malaria	0.000638	0.0022	CcSEcCtD
Fulvestrant—Abdominal pain—Pentoxifylline—malaria	0.000637	0.0022	CcSEcCtD
Fulvestrant—Body temperature increased—Pentoxifylline—malaria	0.000637	0.0022	CcSEcCtD
Fulvestrant—Pruritus—Quinidine—malaria	0.000633	0.00218	CcSEcCtD
Fulvestrant—Pruritus—Quinine—malaria	0.000633	0.00218	CcSEcCtD
Fulvestrant—Diarrhoea—Clindamycin—malaria	0.000624	0.00215	CcSEcCtD
Fulvestrant—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.000622	0.0334	CbGpPWpGaD
Fulvestrant—Diarrhoea—Quinidine—malaria	0.000612	0.00211	CcSEcCtD
Fulvestrant—Diarrhoea—Quinine—malaria	0.000612	0.00211	CcSEcCtD
Fulvestrant—Dizziness—Clindamycin—malaria	0.000603	0.00208	CcSEcCtD
Fulvestrant—Vomiting—Dapsone—malaria	0.0006	0.00207	CcSEcCtD
Fulvestrant—Hypersensitivity—Quinidine barbiturate—malaria	0.000595	0.00205	CcSEcCtD
Fulvestrant—Hypersensitivity—Pentoxifylline—malaria	0.000594	0.00205	CcSEcCtD
Fulvestrant—Dizziness—Quinine—malaria	0.000592	0.00204	CcSEcCtD
Fulvestrant—Dizziness—Quinidine—malaria	0.000592	0.00204	CcSEcCtD
Fulvestrant—Headache—Dapsone—malaria	0.000591	0.00204	CcSEcCtD
Fulvestrant—Vomiting—Clindamycin—malaria	0.00058	0.002	CcSEcCtD
Fulvestrant—Asthenia—Quinidine barbiturate—malaria	0.000579	0.002	CcSEcCtD
Fulvestrant—Asthenia—Pentoxifylline—malaria	0.000578	0.00199	CcSEcCtD
Fulvestrant—Rash—Clindamycin—malaria	0.000575	0.00198	CcSEcCtD
Fulvestrant—Dermatitis—Clindamycin—malaria	0.000575	0.00198	CcSEcCtD
Fulvestrant—Headache—Clindamycin—malaria	0.000571	0.00197	CcSEcCtD
Fulvestrant—Pruritus—Quinidine barbiturate—malaria	0.000571	0.00197	CcSEcCtD
Fulvestrant—Pruritus—Pentoxifylline—malaria	0.00057	0.00197	CcSEcCtD
Fulvestrant—Vomiting—Quinidine—malaria	0.000569	0.00196	CcSEcCtD
Fulvestrant—Vomiting—Quinine—malaria	0.000569	0.00196	CcSEcCtD
Fulvestrant—ESR1—Leptin signaling pathway—CISH—malaria	0.000567	0.0304	CbGpPWpGaD
Fulvestrant—Rash—Quinine—malaria	0.000564	0.00194	CcSEcCtD
Fulvestrant—Rash—Quinidine—malaria	0.000564	0.00194	CcSEcCtD
Fulvestrant—Dermatitis—Quinine—malaria	0.000564	0.00194	CcSEcCtD
Fulvestrant—Dermatitis—Quinidine—malaria	0.000564	0.00194	CcSEcCtD
Fulvestrant—Headache—Quinine—malaria	0.000561	0.00193	CcSEcCtD
Fulvestrant—Headache—Quinidine—malaria	0.000561	0.00193	CcSEcCtD
Fulvestrant—Nausea—Dapsone—malaria	0.00056	0.00193	CcSEcCtD
Fulvestrant—Diarrhoea—Quinidine barbiturate—malaria	0.000553	0.0019	CcSEcCtD
Fulvestrant—Diarrhoea—Pentoxifylline—malaria	0.000552	0.0019	CcSEcCtD
Fulvestrant—Nausea—Clindamycin—malaria	0.000542	0.00187	CcSEcCtD
Fulvestrant—Dizziness—Quinidine barbiturate—malaria	0.000534	0.00184	CcSEcCtD
Fulvestrant—Dizziness—Pentoxifylline—malaria	0.000533	0.00184	CcSEcCtD
Fulvestrant—Nausea—Quinine—malaria	0.000532	0.00183	CcSEcCtD
Fulvestrant—Nausea—Quinidine—malaria	0.000532	0.00183	CcSEcCtD
Fulvestrant—Vomiting—Quinidine barbiturate—malaria	0.000513	0.00177	CcSEcCtD
Fulvestrant—Vomiting—Pentoxifylline—malaria	0.000513	0.00177	CcSEcCtD
Fulvestrant—Rash—Quinidine barbiturate—malaria	0.000509	0.00175	CcSEcCtD
Fulvestrant—Dermatitis—Quinidine barbiturate—malaria	0.000509	0.00175	CcSEcCtD
Fulvestrant—Rash—Pentoxifylline—malaria	0.000508	0.00175	CcSEcCtD
Fulvestrant—Dermatitis—Pentoxifylline—malaria	0.000508	0.00175	CcSEcCtD
Fulvestrant—Headache—Quinidine barbiturate—malaria	0.000506	0.00174	CcSEcCtD
Fulvestrant—Headache—Pentoxifylline—malaria	0.000505	0.00174	CcSEcCtD
Fulvestrant—Nausea—Quinidine barbiturate—malaria	0.00048	0.00165	CcSEcCtD
Fulvestrant—Nausea—Pentoxifylline—malaria	0.000479	0.00165	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000446	0.0239	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000424	0.0228	CbGpPWpGaD
Fulvestrant—ESRRA—PPARA activates gene expression—CD36—malaria	0.000399	0.0214	CbGpPWpGaD
Fulvestrant—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	0.00039	0.0209	CbGpPWpGaD
Fulvestrant—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.000377	0.0202	CbGpPWpGaD
Fulvestrant—NR1H4—Biological oxidations—HPGDS—malaria	0.000354	0.019	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000339	0.0182	CbGpPWpGaD
Fulvestrant—NR1H4—PPARA activates gene expression—CD36—malaria	0.000291	0.0156	CbGpPWpGaD
Fulvestrant—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	0.000285	0.0153	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000283	0.0152	CbGpPWpGaD
Fulvestrant—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.000269	0.0144	CbGpPWpGaD
Fulvestrant—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000263	0.0141	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—CD36—malaria	0.000257	0.0138	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC4A1—malaria	0.000251	0.0134	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000248	0.0133	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—DHODH—malaria	0.000236	0.0127	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000232	0.0125	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000213	0.0114	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL10—malaria	0.000206	0.011	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—SLC4A1—malaria	0.000201	0.0108	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL10—malaria	0.000197	0.0106	CbGpPWpGaD
Fulvestrant—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.000196	0.0105	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL4—malaria	0.000192	0.0103	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—DECR1—malaria	0.000189	0.0101	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—DHODH—malaria	0.000189	0.0101	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000186	0.00997	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—malaria	0.000175	0.0094	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—NOS2—malaria	0.000173	0.00929	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—HBB—malaria	0.000171	0.00917	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000171	0.00915	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SLC4A1—malaria	0.000161	0.00862	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000157	0.00841	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PKLR—malaria	0.000152	0.00817	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—DECR1—malaria	0.000151	0.0081	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000143	0.00766	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—DHODH—malaria	0.000138	0.00741	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—HBB—malaria	0.000137	0.00733	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000136	0.00728	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—G6PD—malaria	0.000136	0.00728	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—CD36—malaria	0.000134	0.00718	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IFNG—malaria	0.000133	0.00712	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000125	0.00669	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PKLR—malaria	0.000122	0.00653	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—IFNG—malaria	0.000118	0.00636	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SLC4A1—malaria	0.000117	0.0063	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IFNG—malaria	0.000116	0.00621	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—DECR1—malaria	0.00011	0.00592	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—G6PD—malaria	0.000108	0.00582	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL1B—malaria	0.000108	0.00579	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—CD36—malaria	0.000107	0.00574	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—IL2—malaria	0.000105	0.00565	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—TNF—malaria	0.000105	0.00563	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—HPGDS—malaria	0.000103	0.00555	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL2—malaria	0.000103	0.00552	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HBB—malaria	9.98e-05	0.00535	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—IL1B—malaria	9.77e-05	0.00524	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—DHFR—malaria	9.6e-05	0.00515	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—SCARB1—malaria	9.5e-05	0.0051	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PKLR—malaria	8.9e-05	0.00477	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—HPGDS—malaria	8.27e-05	0.00444	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—G6PD—malaria	7.93e-05	0.00425	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—FAS—malaria	7.91e-05	0.00424	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TNF—malaria	7.83e-05	0.0042	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CD36—malaria	7.82e-05	0.0042	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—DHFR—malaria	7.68e-05	0.00412	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SCARB1—malaria	7.6e-05	0.00408	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—malaria	6.93e-05	0.00372	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—malaria	6.66e-05	0.00357	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—malaria	6.32e-05	0.00339	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—malaria	6.05e-05	0.00324	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HPGDS—malaria	6.05e-05	0.00324	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CD36—malaria	5.96e-05	0.0032	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—DHFR—malaria	5.61e-05	0.00301	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SCARB1—malaria	5.55e-05	0.00298	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—HPGDS—malaria	5.06e-05	0.00272	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CD36—malaria	4.77e-05	0.00256	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CD36—malaria	3.48e-05	0.00187	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ACKR1—malaria	3.45e-05	0.00185	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—malaria	3.36e-05	0.0018	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—malaria	3.25e-05	0.00174	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TLR9—malaria	2.78e-05	0.00149	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DHODH—malaria	1.98e-05	0.00106	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC4A1—malaria	1.68e-05	0.000901	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DECR1—malaria	1.58e-05	0.000848	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HBB—malaria	1.43e-05	0.000766	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PKLR—malaria	1.27e-05	0.000683	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—G6PD—malaria	1.13e-05	0.000609	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KDR—malaria	1.11e-05	0.000593	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HPGDS—malaria	8.65e-06	0.000464	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DHFR—malaria	8.03e-06	0.000431	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SCARB1—malaria	7.95e-06	0.000426	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2—malaria	7.17e-06	0.000385	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CD36—malaria	4.99e-06	0.000268	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—malaria	4.21e-06	0.000226	CbGpPWpGaD
